A recent flurry of lawsuits has "targeted" holders of the BlackRock LifePath target-date funds and their decision(s) to select, and hold, on their investment menu.
Ironically, the plan fiduciaries have been charged with "chasing low fees" with a disregard for the funds' performance—which the plaintiffs say was tracked against an inappropriate benchmark. In this episode, Nevin & Fred look at the issues raised by—and the issues involved in—this new round of ERISA litigation.
Episode Resources
Home Depot Hammers Back Excessive Fee Suit
